Breast cancer following radiotherapy and chemotherapy among young women with Hodgkin disease.

By L. Travis, D. Hill, G. Dores, M. Gospodarowicz, F. V. van Leeuwen, E. Holowaty, B. Glimelius, M. Andersson, T. Wiklund, C. Lynch and 8 more. Journal of the American Medical Association (JAMA), 2003

683 citations recorded by the source corpus.

Subfields: Cancer Research, Oncology, Pathology and Forensic Medicine

View Paper: https://www.semanticscholar.org/paper/46692aabeaeef4ece7b7cb9000065a21be476cd0

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Oncology

1. E. Stovall
2. S. Greenfield
3. M. Hewitt
4. Stephen A. Feig

In Pathology and Forensic Medicine

1. humAn cArcinogens
2. Iarc Monographs
3. peRsonAl hAbIts

Citations in the corpus

• iArc monogrAphs on the evAluAtion oF cArcinogenic risks to humAns (2012, methodology): “A combined analysis of the cohorts of Danish and Swedish Thorotrast patients (Travis et al., 2003) showed statistically significant trends with a surrogate measure for cumulative radiation dose in the incidence of primary liver cancer and cancer of the gallbladder.”
• From cancer patient to cancer survivor : lost in transition (2006, background): “Women with therapy-related premature menopause have a lower risk of subsequent breast cancer (Travis et al., 2003).”
• Breast cancer screening with imaging: recommendations from the Society of Breast Imaging and the ACR on the use of mammography, breast MRI, breast ultrasound, and other technologies for the detection of clinically occult breast cancer. (2010, background): “It is acknowledged that the relative risk for developing breast cancer in these women is high, estimated between 4 and 75 times, particularly when the radiation was delivered between the ages of 10 and 30 or was "4 Gy [39-42].”